Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10002284 | The Journal of the American Dental Association | 2005 | 10 Pages |
Abstract
Symptomatic and asymptomatic gastroparietic patients who do not have severe cardiovascular, cerebral or renal ischemic disease benefit from use of COX-2i. Long-term use of these agents in medically compromised patients may prove disastrous.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
MICHAEL D.D.S., M.D., SAUL D.M.D., M.S.D., ROBERT D.M.D.,